KWMG LLC’s Bristol-Myers Squibb BMY Stock Holding History

KWMG LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-319	Closed	-$15K	–	154
2019 Q1	$15K	Hold	319	–	–	﹤0.01%	245
2018 Q4	$17K	Hold	319	–	–	﹤0.01%	233
2018 Q3	$20K	Hold	319	–	–	0.01%	224
2018 Q2	$18K	Buy	+319	New	+$17.2K	﹤0.01%	227

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

KWMG LLC's BMY Position: Q2 2019 in Review

KWMG LLC sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 319 shares — an estimated $15K sold.

KWMG LLC first reported a position in BMY in Q2 2018 and held it in 4 quarters. The position peaked at $20K in Q3 2018. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

KWMG LLC reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
KWMG LLC sold 319 Bristol-Myers Squibb shares in Q2 2019, an estimated $15K.
KWMG LLC first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 4 quarters.
KWMG LLC's Bristol-Myers Squibb position peaked at $20K in Q3 2018.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on KWMG LLC's 13F filing for Q2 2019, filed 10 Jul 2019.